2667681-71-0

2667681-71-0 structure

Name: IRAK4-IN-14
Chemical Name: IRAK4-IN-14
CAS Number: 2667681-71-0
Molecular Formula: C₂₅H₂₈FN₉O
Molecular Weight: 489.55
Catalog: Signaling Pathways Immunology/Inflammation IRAK
Create Date: 2022-07-01 11:07:19
Modify Date: 2024-01-10 11:23:52
IRAK4-IN-14 (compound 28) is a potent, selective and orally active IRAK4 inhibitor with an IC50 of 0.003 µM. IRAK4-IN-14 shows good PK parameters in rats and mouse. IRAK4-IN-14 shows synergistic in vitro activity against MyD88/CD79 double mutant ABC-DLBCL in combination with Acalabrutinib[1].

Name	IRAK4-IN-14

Description	IRAK4-IN-14 (compound 28) is a potent, selective and orally active IRAK4 inhibitor with an IC50 of 0.003 µM. IRAK4-IN-14 shows good PK parameters in rats and mouse. IRAK4-IN-14 shows synergistic in vitro activity against MyD88/CD79 double mutant ABC-DLBCL in combination with Acalabrutinib[1].
Related Catalog	Research Areas >> Cancer Signaling Pathways >> Immunology/Inflammation >> IRAK Signaling Pathways >> Protein Tyrosine Kinase/RTK >> IRAK
Target	IRAK4:0.003 μM (IC50)
In Vitro	IRAK4-IN-14 (compound 28) shows cell pIRAK4 potencies with an IC50 of 0.11 µM[1]. IRAK4-IN-14 (compound 28) shows selectivity with IC50s of 0.003,1.4, >8, >9, 0.053, 0.27, 0.76, 0.27 µM for IRAK4, IRAK1, BTK, Flt3, PI3Kδ, TRKa, TRKb, TRKc, respectively[1].
In Vivo	IRAK4-IN-14 (i.v. or p.o.) shows good PK parameters with oral bioavailability of 66% for mouse[1]. Pharmacokinetic Parameters of IRAK4-IN-14 in Male Han Wistar rats, male CD1 mice, male Cynomolgus monkeys[1]. parameter Value A2B Papp 31 Efflux ratio 1.4 Solubility (µM) 800 Rat/mouse/monkey/human %free 21/16/33/21 Rat LM/H CLint 16/5.6 Mouse LM/H CLint 13/11 Minipig LM/H CLint 18/8.2 Dog LM/H CLint 21/4.5 Monkey LM/H CLint 35/4.7 Rat CL 15 Vdss 4.3 t1/2 5.2 F% 55% Mouse CL 17 Vdss 4.1 t1/2 4.2 F% 66% Monkey CL 68 Vdss 8.6 t1/2 1.4Male Han Wistar rats; 1 mg/kg i.v.; 2 mg/kg p.o.; Male CD1 mice; 0.5 mg/kg i.v.; 1 mg/kg p.o.; Male Cynomolgus monkeys; 1 mg/kg i.v.[1].
References	[1]. Degorce SL, et al. Improving metabolic stability and removing aldehyde oxidase liability in a 5-azaquinazoline series of IRAK4 inhibitors. Bioorg Med Chem. 2020 Dec 1;28(23):115815.

Molecular Formula	C₂₅H₂₈FN₉O
Molecular Weight	489.55

The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.

2667681-71-0	1820787-94-7
1812188-83-2	2681278-07-7
2667681-57-2	2681278-09-9
2033070-97-0	2667681-85-6
509093-72-5	2170694-04-7
453565-62-3	453566-98-8
1081118-70-8	453565-67-8
453568-67-7	453567-23-2
851365-09-8	453567-08-3
453565-82-7	1042791-85-4